Drug Approval | December 26, 2025
Japan nod to Dupixent for children with severe asthma
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
The combination also outperformed chemotherapy on another important secondary endpoint
Hansoh Pharma will receive an upfront payment in the low double-digit millions
Subscribe To Our Newsletter & Stay Updated
